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a b s t r a c t
Cytochrome P450 gene expression is altered by various chemical compounds. In this study, we used
nuclear factor erythroid 2-related factor 2 (Nrf2)–deﬁcient (Nrf2⧸) mice to investigate the involve-
ment of Nrf2 in Cyp2b10 and Cyp2a5 gene expression. Phorone, an Nrf2 activator, strongly increased
Cyp2b10 and Cyp2a5 mRNA as well as Nrf2 target genes, including NAD(P)H-quinone oxidoreductase-1
and heme oxygenase-1, in wild-type mouse livers 8 h after treatment. The phorone-induced mRNA levels
in Nrf2⧸ mouse livers were lower than that in wild-type mouse livers. Nrf2⧸ mice showed
attenuated Cyp2b10 and Cyp2a5 induction by phenobarbital, a classical Cyp2b inducer. These ﬁndings
suggest that the Nrf2 pathway is involved in Cyp2b10 and Cyp2a5 gene expression.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Introduction
Cytochrome P450s (P450s) are phase I detoxiﬁcation enzymes that
catalyze various reactions such as oxidation, reduction, and dehalo-
genation to metabolize endogenous and exogenous compounds [1,2].
P450 gene expression can be extensively regulated by a number of
factors including xenobiotics (e.g., phenobarbital). Previous studies
have investigated the transcriptional activation of P450s and several
xenobiotic-activated receptors, such as aryl hydrocarbon receptor,
constitutive androstane receptor (CAR), and pregnane X receptor [3],
which act as speciﬁc transcription factors. Recent investigations have
demonstrated that nuclear factor erythroid 2-related factor 2 (Nrf2)
functions as a transcription factor for the Cyp2a5 gene [4]; however, its
involvement in other P450 genes is unclear.
Nrf2 is transferred to the nucleus when it and its anchoring
protein, Kelch-like ECH-associated protein 1, respond to oxidative
stressors such as electrophiles. Nuclear Nrf2 heterodimerizes to the
small musculoaponeurotic ﬁbrosarcoma oncogene homolog (Maf),
a transcriptional activator, and positively regulates gene expression by
binding to the antioxidant response element (ARE) located upstream
of the target genes [5]. Thus, the Nrf2 system is a gene regulator of
biological defense proteins, such as antioxidant proteins, associated
proteins of glutathione synthesis, and phase II detoxiﬁcation enzymes
[5], which suggests that this transcription factor has multiple func-
tions. α,β-Unsaturated carbonyl compounds, such as phorone, induce
NAD(P)H-quinone oxidoreductase-1 (Nqo1) and heme oxygenase-1
(Hmox1), particularly in the liver [6,7]. These effects are due to Nrf2
activation followed by an increase in ARE binding because Nqo1 [8]
and Hmox1 [9] are genes that are known to be regulated by Nrf2. The
present study provides evidence that Nrf2 is involved in phorone- and
phenobarbital-induced P450 gene expression changes in mouse
livers. These results suggest that chemical compounds associated
with Nrf2 activation modify Cyp2b10 and Cyp2a5 gene expression.
Materials and methods
Materials
Phorone was from Wako Pure Chemical Industries (Tokyo, Japan).
Phenobarbital sodium salt was from Tokyo Chemical Industry (Tokyo,
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Japan). All other reagents used were of the highest grade commercially
available.
Animals and treatments
All mouse experiments were carried out under the control of
the Committee Regulation of Animal Care and Welfare of Showa
University. Male C57BL/6 mice (8 weeks old) were purchased from
Japan SLC (Shizuoka, Japan). The Nrf2-deﬁcient (Nrf2⧸) mice
were established by Itoh et al. [10]. Phorone (2 mmol/kg) was
dissolved in corn oil and injected intraperitoneally; a dose of
2 mmol/kg is used for most of these Hmox1 induction studies [6].
Phenobarbital (100 mg/kg) was dissolved in saline and injected
intraperitoneally; a dose of 100 mg/kg is used for most of these
P450 induction studies [11]. Control mice were injected with
respective vehicles in volumes similar to that of the treated mice.
All protocols used in this study were reviewed and approved by
the Institutional Animal Care and Use Committee of Showa
University (#27003).
Quantitative real-time polymerase chain reaction (PCR)
Total RNA was isolated from the liver using RNeasy Mini Kit
(QIAGEN, Valencia, CA), and ﬁrst-stranded cDNA was synthesized
with a PrimeScript RT reagent Kit (Takara Bio, Shiga, Japan). The
quantitative real-time PCR was performed according to the man-
ufacturer0s protocol using StepOne real-time PCR system (Life
Technologies, Carlsbad, CA), SYBR Premix Ex Taq (Takara Bio),
and TaqMan Fast Universal Master Mix (Life Technologies). The
PCR primer and TaqMan MGB Probe were purchased from Takara
Bio or Life Technologies. The mRNA levels were measured as the
relative ratio to glyceraldehyde-3-phosphate dehydrogenase
(Gapdh) mRNA.
Statistical analysis
Statistical analysis was performed using the Kruskal–Wallis
non-parametric analysis, with the Dunnett test or the Scheffe test
for post hoc comparisons. The accepted level of signiﬁcance was
set at po0.05.
Results
Phorone, an α,β-unsaturated carbonyl compound, induces Nrf2 target
genes in mouse livers
Nrf2 transcriptionally regulates Nqo1 and Hmox1 [12,13]. We
previously reported that phorone (Fig. 1A) is a potent inducer of
Hmox1 in rat livers [6]. However, its effects on other Nrf2 target
genes in mouse livers were unclear. Thus, we ﬁrst performed time-
course experiments to conﬁrm phorone inductions of Nqo1 and
Hmox1 in wild-type (WT) mouse livers. Phorone (2 mmol/kg)
increased Nqo1 mRNA 4 h after treatment and reached 890% of the
control level by 8 h (Fig. 1B). Further, phorone increased Hmox1
mRNA 2 h after treatment and reached a peak level of 3800% of the
control level by 4 h (Fig. 1C).
Phorone induces Cyp2b10 and Cyp2a5 gene expression in mouse
livers
Because phorone induced Nrf2 target genes, we next examined
its effect on P450 gene expression. Phorone enhanced the gene
expression of various P450 species; in particular Cyp2b10 and
Cyp2a5 mRNA were markedly increased 8 h after treatment
(1800% and 1100% of the control, respectively) (Fig. 2). Phorone
also signiﬁcantly induced Cyp1a2 and Cyp3a11, although this
induction was extremely low as compared with that of Cyp2b10
and Cyp2a5.
Attenuation of Cyp2b10 and Cyp2a5 induction by phorone in Nrf2 /
mouse livers
Phorone robustly induced Cyp2b10 and Cyp2a5 in WT mouse
livers (Fig. 2). Therefore, to elucidate the Nrf2 involvement in
Cyp2b10 and Cyp2a5 induction, we investigated the amount of
Cyp2b10 and Cyp2a5 mRNA increased by phorone using Nrf2⧸
mice. As shown in Fig. 3, Cyp2b10, Cyp2a5, and Nqo1 mRNA levels
of the controls were lower in Nrf2⧸ mice livers compared with
those in WT mice livers. Phorone signiﬁcantly increased Cyp2b10
(1200% of the control), Cyp2a5 (300% of the control), and Nqo1
mRNA (720% of the control) in WT mouse livers at 8 h after
treatment (in a way similar to what is shown in Figs. 1B and 2).
Cyp2b10 mRNA levels in phorone-treated Nrf2⧸ mouse livers
were signiﬁcantly lower than that in the corresponding WT mouse
livers (23% of the phorone-treated WT mouse livers) (Fig. 3A),
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Fig. 1. The effects of phorone on Nqo1 and Hmox1 gene expression in mouse livers.
(A) Structure of phorone. (B and C) Mice were injected intraperitoneally with
phorone or corn oil, and their livers were excised at the times indicated. The mRNA
levels were determined by real-time PCR and semiquantiﬁed by normalizing to
Gapdh mRNA. Values represent the mean7S.E.M. (n¼3). The signiﬁcant difference
was assessed by the Kruskal–Wallis non-parametric analysis followed by the
Dunnett test. nPo0.05 vs. control mice.
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and phorone failed to induce Cyp2a5 and Nqo1 in Nrf2⧸ mouse
livers (Fig. 3B and C).
Nrf2 is involved in phenobarbital-induced Cyp2b10 and Cyp2a5 gene
expression in mouse livers
Phenobarbital (Fig. 4A) is a classical Cyp2b10 inducer. To
further assess the involvement of Nrf2 in Cyp2b10 and Cyp2a5
induction, we treated WT and Nrf2⧸ mice with phenobarbital
and measured Cyp2b10 and Cyp2a5 mRNA levels in the livers.
Phenobarbital markedly increased Cyp2b10 (8540% of the con-
trols), Cyp2a5 (420% of the controls), and Nqo1 mRNAs (160% of
the controls) 12 h after treatment in WT mice (Fig. 4B–D). Nrf2⧸
mice showed signiﬁcantly suppressed phenobarbital-induced
Cyp2b10 gene expression (43% of the phenobarbital-treated WT
mice). Similar to the phorone treatment, phenobarbital failed to
induce Cyp2a5 and Nqo1 in Nrf2⧸ mouse livers.
Discussion
The Nrf2 pathway mediates the antioxidant response, which is
an important cellular defense mechanism that leads to the induc-
tion of several chemoprotective and antioxidative genes, including
Nqo1, Hmox1, glutathione S-transferases, and multidrug resist-
ance-associated proteins [14,15]. In the present study, we demon-
strated that in mouse livers, the redox-sensitive transcription
factor Nrf2 is involved in the gene expression of phase I drug-
metabolizing enzymes Cyp2b10 and Cyp2a5. These results suggest
that Nrf2 functions as a key regulator for the cellular detoxiﬁcation
of xenotoxins and in the cellular redox homeostasis.
Because α,β-unsaturated carbonyl compounds, including phor-
one, have an electrophilic carbon, these compounds deplete a
major intracellular antioxidant glutathione and induce oxidative
stress, thereby activating Nrf2 [7,16]. Endogenous α,β-unsaturated
carbonyl compounds, such as 15-deoxy-Δ12,14-prostaglandin J2,
a prostaglandin D2 dehydration product, and 4-hydroxy-2-none-
nal, a lipid peroxidation product, also activate Nrf2 and potently
induce antioxidant proteins [7,13]. In this study, we demonstrated
that phorone induces Nqo1 and Hmox1 but failed to induce Nqo1
mRNA in Nrf2⧸ mouse livers, suggesting that phorone activates
the Nrf2 pathway. Furthermore, we found that phenobarbital
signiﬁcantly induces Nqo1 gene expression. However, its induction
was not observed in Nrf2⧸ mouse livers. Thus, these results
suggest that phenobarbital also activates Nrf2 in mouse livers.
The mechanism by which xenobiotics induce Cyp2b gene expres-
sion has been well described. On being exposed to an inducer, CAR
translocates into the nucleus forming a heterodimer with the retinoid
X receptor and activates the phenobarbital responsive elementmodule
(PBREM), which is located upstream of the Cyp2b gene family [17].
CAR is either directly controlled by an agonist ligand, such as 1,4-bis
[2-(3,5-dichloropyridyloxy)]benzene [18], or indirectly controlled by
inducers, such as phenobarbital [17,19,20]. The overall mechanism that
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Fig. 2. The effects of phorone on P450 gene expression in mouse livers. Mice were
injected intraperitoneally with phorone or corn oil, and their livers were excised at
the times indicated. The mRNA levels were determined by real-time PCR and
semiquantiﬁed by normalizing to Gapdh mRNA. Values represent the mean7S.E.
M. (n¼3). The signiﬁcant difference was assessed by the Kruskal–Wallis non-
parametric analysis followed by the Dunnett test. nPo0.05 vs. control mice.
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Fig. 3. Phorone suppressed the induction of Cyp2b10, Cyp2a5, and Nqo1 mRNA in
Nrf2⧸ mouse livers. (A–C) Mice were injected intraperitoneally with phorone or
corn oil, and their livers were excised 8 h after treatment. The mRNA levels were
determined by real-time PCR and semiquantiﬁed by normalizing to Gapdh mRNA.
Values represent the mean7S.E.M. (n¼4–5). The signiﬁcant difference was
assessed by the Kruskal–Wallis non-parametric analysis followed by the Scheffé
test (nPo0.05, nnPo0.01 and nnnPo0.001).
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causes phenobarbital-mediated nuclear translocation of CAR, a key
step in the transactivation of target genes, is unclear. In contrast, Nrf2
activators, such as trans-Stilbene oxide and oltipraz, activate the
CYP2B6 promoter- (including PBREM) luciferase reporter construct
[21,22]. In this study, phorone signiﬁcantly induced Cyp2b10 gene
expression in mouse livers, and this suggests that phorone activates
CAR, resulting in the activation of PBREM. However, the mechanism
for CAR activation by Nrf2 activators and phenobarbital is still unclear.
Furthermore, we showed that Cyp2b10 induction by phorone and
phenobarbital is attenuated in Nrf2⧸ mouse livers, suggesting that
the Nrf2 pathway may also be involved in phorone-induced Cyp2b10
gene expression.
The present study demonstrated that phorone robustly increa-
ses Cyp2a5 mRNA in mouse livers. Abu-Balar et al. reported that
Cyp2a5 is induced by cadmium chloride, and its induction is
directly controlled by Nrf2 [4]. This study is the ﬁrst example of
a P450 gene that is regulated by Nrf2. We also report here on the
complete failure of phorone to induce Cyp2a5 in Nrf2⧸ mouse
livers. In line with our data, it has been previously shown that
non-alcoholic fatty liver disease mediates oxidative stress followed
by Cyp2a5 induction via Nrf2 activation [23]. These results suggest
that phorone-induced oxidative stress enhances Cyp2a5 gene
expression, which is regulated by the Nrf2 system. Furthermore,
we found that phenobarbital signiﬁcantly induces Cyp2A5 in
mouse livers. Consistent with our observations, Salonpaa et al.
reported that phenobarbital induced Cyp2a5 in mouse primary
hepatocytes. However, little is known about the involvement of
CAR in phenobarbital-induced Cyp2a5 gene expression. Thus,
using gene-deﬁcient mice, we demonstrated that Nrf2 depletion
inhibits phenobarbital-induced Cyp2a5 gene expression. These
results suggest that phenobarbital activates Nrf2, thereby inducing
Cyp2a5.
In conclusion, the present study demonstrated that phorone,
an Nrf2 activator, and phenobarbital, a CAR activator, induced both
Cyp2b10 and Cyp2a5, and these inductions are involved in the Nrf2
pathway. It is expected that the Nrf2 pathway regulates the
expression of drug metabolizing enzymes and antioxidant proteins
along with the maintenance of cellular homeostasis. Nrf2 and CAR
primarily play a role in induction of similar phase I and phase II
drug metabolizing enzymes [24]. However, the presence of Nrf2
binding domains (corresponding to ARE in the Cyp2b10 promoter
region) and CAR binding domains (corresponding to PBREM in the
Cyp2a5 promoter region) has not been explained. These reports
suggest that there is an interaction between Nrf2 and CAR, which is
involved in the inducible regulation of drug metabolizing enzymes.
Thus, further studies are required to elucidate the interaction
between Nrf2 and CAR in the regulation of P450 gene expression.
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intraperitoneally with phenobarbital or saline, and their livers were excised 12 h after treatment. The mRNA levels were determined by real-time PCR and semiquantiﬁed by
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